IL17REL | Interleukin 17 receptor E-like | Predicted intracellular proteins
| | | | | Tissue enhanced |
KRT20 | Keratin 20 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
KRT8 | Keratin 8 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
LBX2 | Ladybird homeobox 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
LGALS9B | Lectin, galactoside-binding, soluble, 9B | Predicted intracellular proteins
| | | | | Tissue enhanced |
LGALS9C | Lectin, galactoside-binding, soluble, 9C | Predicted intracellular proteins
| | | | | Tissue enhanced |
LRRC75A | Leucine rich repeat containing 75A | Predicted intracellular proteins
| | | | | Tissue enhanced |
MIA2 | Melanoma inhibitory activity 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
MISP | Mitotic spindle positioning | Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MLPH | Melanophilin | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NOXO1 | NADPH oxidase organizer 1 | FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
NPSR1 | Neuropeptide S receptor 1 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
PAX4 | Paired box 4 | Disease related genes Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Tissue enhanced |
PHGR1 | Proline/histidine/glycine-rich 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PIGR | Polymeric immunoglobulin receptor | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PLS1 | Plastin 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
PPP1R1B | Protein phosphatase 1, regulatory (inhibitor) subunit 1B | Predicted intracellular proteins
| | | | | Tissue enhanced |
PRAP1 | Proline-rich acidic protein 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PRR15 | Proline rich 15 | Predicted intracellular proteins
| | | | | Tissue enhanced |
REG1B | Regenerating islet-derived 1 beta | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RNF186 | Ring finger protein 186 | Predicted membrane proteins
| | | | | Tissue enhanced |
RP11-1220K2.2 | Homo sapiens maltase-glucoamylase (alpha-glucosidase) (LOC93432), mRNA. | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
SCGN | Secretagogin, EF-hand calcium binding protein | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SCIN | Scinderin | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SECTM1 | Secreted and transmembrane 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SLC23A1 | Solute carrier family 23 (ascorbic acid transporter), member 1 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC28A2 | Solute carrier family 28 (concentrative nucleoside transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC3A1 | Solute carrier family 3 (amino acid transporter heavy chain), member 1 | Disease related genes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enhanced |
SLC51B | Solute carrier family 51, beta subunit | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLX1A-SULT1A3 | SLX1A-SULT1A3 readthrough (NMD candidate) | Predicted intracellular proteins
| | | | | Tissue enhanced |
SMIM6 | Small integral membrane protein 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
SOWAHA | Sosondowah ankyrin repeat domain family member A | Predicted secreted proteins
| | | | | Tissue enhanced |
SULT1A2 | Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
TFF3 | Trefoil factor 3 (intestinal) | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TMC5 | Transmembrane channel-like 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM229A | Transmembrane protein 229A | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM45B | Transmembrane protein 45B | Predicted membrane proteins
| | | | | Tissue enhanced |
TNFRSF11A | Tumor necrosis factor receptor superfamily, member 11a, NFKB activator | CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TSPAN8 | Tetraspanin 8 | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
UGT2A3 | UDP glucuronosyltransferase 2 family, polypeptide A3 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
UPK1B | Uroplakin 1B | Predicted membrane proteins
| | | | | Tissue enhanced |
VILL | Villin-like | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
VSIG2 | V-set and immunoglobulin domain containing 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
ZG16 | Zymogen granule protein 16 | Predicted secreted proteins
| | | | | Tissue enhanced |